Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants

In 2016, there were more cases and deaths caused by malaria globally than in 2015. An effective vaccine would be an ideal additional tool for reducing malaria’s impact. Sanaria(®) PfSPZ Vaccine, composed of radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum (Pf) sporozoites...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Trop Med Hyg
Main Authors: Jongo, Said A., Church, L. W. Preston, Mtoro, Ali T., Chakravarty, Sumana, Ruben, Adam J., Swanson, Phillip A., Kassim, Kamaka R., Mpina, Maximillian, Tumbo, Anneth-Mwasi, Milando, Florence A., Qassim, Munira, Juma, Omar A., Bakari, Bakari M., Simon, Beatus, James, Eric R., Abebe, Yonas, KC, Natasha, Saverino, Elizabeth, Gondwe, Linda, Studer, Fabian, Fink, Martina, Cosi, Glenda, El-Khorazaty, Jill, Styers, David, Seder, Robert A., Schindler, Tobias, Billingsley, Peter F., Daubenberger, Claudia, Sim, B. Kim Lee, Tanner, Marcel, Richie, Thomas L., Abdulla, Salim, Hoffman, Stephen L.
Formato: Artigo
Idioma:Inglês
Publicado: The American Society of Tropical Medicine and Hygiene 2019
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553883/
https://ncbi.nlm.nih.gov/pubmed/30994090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.18-0835
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares